Atnahs Pharma Denmark ApS: Financial statements 2021
CVR: 36699051
Source: annual report 2021, Danish Business Authority
01/04/2020 – 31/03/2021
Atnahs Pharma Denmark ApS (CVR 36699051) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 5,092,802 and a net result of DKK 275,303 compared with DKK -1,418,130 the year before. Equity in the 2021 report amounted to DKK -3,504,789.
- Gross Profit
- DKK 5,092,802
- Profit/Loss
- DKK 275,303
- Equity
- DKK -3,504,789
- Total Assets
- DKK 127,940,398
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 5.1M | 275K | -3.5M | - |
| 2020 | - | -1.3M | -1.4M | -3.8M | - |
| 2019 | - | 779K | -1.1M | -2.4M | - |
| 2018 | - | -1.4M | -1.9M | -1.3M | - |
Official annual report
Find more companies like Atnahs Pharma Denmark ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 17, 2021, James Charles Burt has joined the board of directors of Atnahs Pharma Denmark ApS.
As of December 17, 2021, Alastair Thomas Badgett Hay has left the board of directors of Atnahs Pharma Denmark ApS.
As of June 16, 2021, Felipe Andres Florez Arango has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 10, 2021, Jesper Wilhelm Voss has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 10, 2021, Svend Aage Johansen has left the board of directors of Atnahs Pharma Denmark ApS.
About Atnahs Pharma Denmark ApS
Atnahs Pharma Denmark ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Pharmamentum ApS. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported revenue of EUR 52,583,756 and a net result of EUR 12,487 compared with DKK 47,843 the year before. Equity in the 2026 report amounted to EUR 2,094,136.